https://www.biospace.com/compugen-ltd-second-quarter-2017-conference-call-scheduled-for-wednesday-august-2-2017-at-10-00-am-et
Compugen Ltd. Second Quarter 2017 Conference Call Scheduled For Wednesday, August 2, 2017 At 10:00...
https://www.thepharmaletter.com/pharma-news/bayer-milestone-for-compugen-in-cancer-immunotherapy-deal
Bayer milestone for Compugen in cancer immunotherapy deal | The Pharmaletter
Bayer milestone for Compugen in cancer immunotherapy deal
in cancerbayermilestonecompugenimmunotherapy
https://www.pmjobs.ca/job/7df52349-c28f-4f7c-ba43-3df5de2e317b
Senior Application Developer - 2 Month Contract at Compugen Inc (Toronto, ON) |...
Apply for Senior Application Developer - 2 Month Contract position at Compugen Inc. Contract. Located in Toronto, ON. Salary: $97,500-$107,250/annually
application developerseniormonth
https://business.wapakdailynews.com/wapakdailynews/quote/news?ChannelType=NEWS&CurrentPage=1&Symbol=NQ%3ACGEN
User | wapakdailynews.com - Latest News about Compugen Ltd. - Ordinary Shares (Nasdaq:CGEN) |...
latest news
https://www.compugen.com/en-ca/contact
Contact Compugen
Contact the Compugen team. Here's how you can get in touch with our team of experts:
compugen
https://campus.compugen.com/
Compugen Campus
Campus Compugen offers educational training activities for iPad, Apple, Google, Jamf, Promethean and Microsoft.
compugencampus
https://www.biospace.com/compugen-to-host-conference-call-to-discuss-exclusive-license-agreement-with-gilead-for-com503-novel-immuno-oncology-pre-clinical-program-harnessing-il-18-biology
Compugen to Host Conference Call to Discuss Exclusive License Agreement with Gilead for COM503,...
Dec 20, 2023 - Compugen Ltd. today announced that it will host a conference call at 8:30 AM ET today, to discuss the exclusive license agreement with Gilead announced today,...
https://www.biospace.com/compugen-to-receive-milestone-payment-triggered-by-dosing-of-first-patient-in-the-second-phase-3-trial-evaluating-rilvegostomig
Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3...
May 30, 2024 - Compugen Ltd. today announced it is entitled to receive a milestone payment from AstraZeneca (LSE/STO/Nasdaq: AZN) triggered by the dosing of the first patient...